BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17169552)

  • 1. Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy.
    Sala A; Mattano LA; Barr RD
    Eur J Cancer; 2007 Mar; 43(4):683-9. PubMed ID: 17169552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis in children and adolescents with cancer.
    Barr RD; Sala A
    Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):483-5; discussion 486. PubMed ID: 18064641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
    Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
    Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia.
    Vora A
    Br J Haematol; 2011 Dec; 155(5):549-60. PubMed ID: 22077340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal toxicities of treatment in children with cancer.
    Kaste SC
    Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):469-73; discussion 486. PubMed ID: 18064652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of complications of bisphosphonates in oncology patients: jaw osteonecrosis].
    Madrid C; Jaques B; Bouferrache K; Broome M
    Rev Med Suisse; 2007 May; 3(112):1322, 1324-6, 1329-31. PubMed ID: 17596069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteonecroses of the bilateral tali during maintenance therapy in a child with acute lymphoblastic leukemia].
    Nozaki H; Matsubara K; Mori S
    Rinsho Ketsueki; 2006 Feb; 47(2):106-10. PubMed ID: 16529012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI evaluation of aseptic osteonecrosis in children over the course of hyperbaric oxygen therapy.
    Scherer A; Engelbrecht V; Bernbeck B; May P; Willers R; Göbel U; Mödder U
    Rofo; 2000 Oct; 172(10):798-801. PubMed ID: 11111290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia.
    Riccio I; Pota E; Marcarelli M; Affinita MC; Di Pinto D; Indolfi C; Del Regno N; Esposito M
    Pediatr Med Chir; 2016 Nov; 38(3):118. PubMed ID: 28009137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
    Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
    Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
    Ruggiero SL; Mehrotra B
    Annu Rev Med; 2009; 60():85-96. PubMed ID: 18928335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
    J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From marrow oedema to osteonecrosis: common paths in the development of post-transplant bone pain.
    Elder GJ
    Nephrology (Carlton); 2006 Dec; 11(6):560-7. PubMed ID: 17199798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term health status among survivors of childhood cancer: does sex matter?
    Armstrong GT; Sklar CA; Hudson MM; Robison LL
    J Clin Oncol; 2007 Oct; 25(28):4477-89. PubMed ID: 17906209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with treatment of malignancies: a focus on avascular necrosis of the bone.
    Newland AM; Lawson AP; Adams VR
    Orthopedics; 2010 Jun; 33(6):413-6. PubMed ID: 20806750
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
    Hewitt C; Farah CS
    J Oral Pathol Med; 2007 Jul; 36(6):319-28. PubMed ID: 17559492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.